openPR Logo
Press release

Leiber GmbH expands international aquaculture business relationship

05-13-2014 06:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Leiber GmbH

Leiber GmbH expands international aquaculture business

By signing the distribution contract between Leiber GmbH and the company PHARMAQ AS, headquartered in Norway, Leiber GmbH teams up with a further distribution partner in the growing markets of aquaculture and expands its existing business activities.

PHARMAQ AS develops, produces and markets vaccines and health products for the global fish farming industry. Their customers are found in the salmonid, tilapia, pangasius, sea bass and bream segments. “Pharmaq provides an excellent platform to extend a broad network in the continuously growing market of the aquaculture industry”, Nicolaus Jungbluth, Business Unit Director Animal Nutrition at Leiber GmbH, appreciates the partnership. He also adds: “PHARMAQ brings an outstanding competence in the field of fish health and fish immunology. Through the cooperation we are able to exchange further important experiences in this field and assure both parties’ positions in the market.

For 60 years, Leiber GmbH, located in Bramsche in Lower Saxony, has been one of the leading manufacturers of specialist yeast products “made in Germany”. The natural raw material brewers’ yeast is processed using an innovative biotechnological method to form high-quality products which are used in the areas of animal nutrition, food, food supplements and biotechnology. With two locations in Lower Saxony, as well as further production sites in Poland and Russia, Leiber manufactures brewers’ yeast products and yeast extracts of the highest quality with over 170 committed members of staff.

Leiber GmbH
Hafenstraße 24
49565 Bramsche
Telefon: +49 (0) 5461 / 9303-0
Telefax: +49 (0) 5461 / 9303-28
E-Mail: info@leibergmbh.de
www.leibergmbh.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leiber GmbH expands international aquaculture business relationship here

News-ID: 287334 • Views: 1950

More Releases from Leiber GmbH

Leiber animal nutrition – Gold medal and innovation prize in Poland
This year's visit to the FERMA trade fair was crowned with shining success for Leiber GmbH and its Polish daughter company - Leiber Sp. z. o.o. based in Krosniewice. This year, the animal feed department with its brewers' yeast range was, once again, represented at the fair in Lodz. FERMA is regarded as the international trade fair and platform for producers and breeders of livestock, pork and poultry in Poland.
Leiber YeaFi® – The Yeast Fibre Concept!
Leiber GmbH has expanded its product range in the area of combined yeast products and adjusted their feed to meet current market trends. For more than 60 years now, Leiber has been combining pure brewers’ yeast with functional fibre products such as brewers’ grains, malt sprouts or wheat germ in a manufacturing process they developed themselves to protect the nutritional ingredients in brewers’ yeast. For several years, the demand for
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Leiber Subsidiary in Poland receives FSSC 22000 Certification
Leiber Sp. z o.o., the Polish subsidiary of Leiber GmbH, has successfully completed the FSSC 22000 Food Safety System Certification process. FSSC 22000, which is recognised internationally and also by the Global Food Safety Initiative (GFSI), was developed on the basis of the ISO 22000 Standard to define basic requirements for the certification of production processes within the food supply chain. Brewer’s yeast products are manufactured for the foodstuffs and

All 5 Releases


More Releases for PHARMAQ

Aquaculture Vaccines Market Analysis by Top Players, Region, Type, End user, Mar …
Aquaculture Vaccines Market 2019-2024: The global aquaculture vaccines market estimated to be valued US$ XX Mn in 2017 and poised to grow at significant CAGR of 19% over 2018-2025 due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Aquaculture Vaccines Market Drvien by Increase in the Prevalence of Aquaculture
Aquaculture Vaccines Market: Snapshot Analysis by Top Vendors (Pharmaq AS Norway …
Global Aquaculture Vaccines Market 2019-2024: The global aquaculture vaccines market estimated to be valued US$ XX Mn in 2017 and poised to grow at significant CAGR over 2018-2025 due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Key players profiled in the global aquaculture vaccines market include: • Pharmaq AS (Zoetis,
Global Aquaculture Vaccines Market By Vaccine Type, Application, Route of Admini …
Global Aquaculture Vaccines Market By Vaccine Type, Application, Route of Administration, Species and Region. Top Key players are Zoetis, LLC) Merck & Co., Inc. Virbac S.A. and Tecnovax SA. The global aquaculture vaccines market was valued around US$ XX Mn in 2017 and growing at a significant CAGR over eight years forecast period 2018-2025 Precision Business Insights (PBI) in its report titled “Global aquaculture vaccines market: Market Estimation, Dynamics, Regional
Global Aquaculture Vaccines Market was Valued at US$ 328.6 Mn in 2017, Drvien by …
The Global Aquaculture Vaccines Market was valued around US$ 328.6 Mn in 2017 and growing at a significant CAGR over eight years forecast period 2018-2025 owing to increase in prevalence of various aquaculture diseases Precision Business Insights (PBI) in its report titled “Global Aquaculture Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period. The report analyses the
Aquaculture Vaccines Market: Global Market Estimation, Dynamics, Regional Share, …
Aquaculture Vaccines Market: Aquaculture is defined as the rearing, breeding, and harvesting of aquatic organisms such as animals and plants present in the rivers, lakes, ponds, and oceans, major marine species are fish, plants, and shellfish. The major challenge in the fish production process is the development and presence of various diseases which can be prevented by using different types of vaccines. Vaccination to the fishes may help to
Coccidiosis Treatment Market Forecast 2017-2022 Huvepharma, Corid, Intervet, Pha …
Coccidiosis Treatment Market Research Report A market study based on the " Coccidiosis Treatment Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Coccidiosis Treatment Market 2017’. The research report analyses the historical as well as present performance of the worldwide Coccidiosis Treatment industry, and makes predictions on the future status of Coccidiosis Treatment market on the basis of this analysis. Request For Sample